Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)

CNY 13.44

(-0.07%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 9.52 Billion 10.01 Billion 8.21 Billion 7.72 Billion 5.07 Billion 3.4 Billion
Total Current Assets 7.26 Billion 8.29 Billion 6.92 Billion 6.76 Billion 4.28 Billion 2.83 Billion
Cash And Short Term Investments 1.89 Billion 1.38 Billion 918.35 Million 1.33 Billion 420.79 Million 434.8 Million
Cash and Cash Equivalents 1.2 Billion 1.38 Billion 658.55 Million 493.55 Million 364.16 Million 434.8 Million
Short Term Investments 681.98 Million 1.3 Million 259.79 Million 845.79 Million 56.63 Million -2.04 Million
Net Receivables 1.13 Billion 1.24 Billion 1.09 Billion 916.48 Million 523.7 Million 307.37 Million
Inventory 4.15 Billion 5.61 Billion 4.89 Billion 4.45 Billion 3.27 Billion 1.95 Billion
Other Current Assets 73.28 Million 47.53 Million 20.47 Million 54.83 Million 70.41 Million 144.32 Million
Total Non-Current Assets 2.26 Billion 1.71 Billion 1.28 Billion 952.26 Million 789.64 Million 564.3 Million
Net PPE 1.24 Billion 1.19 Billion 827.42 Million 532.83 Million 481.59 Million 471.22 Million
Good Will And Intangible Assets 594.75 Million 337.67 Million 314.79 Million 276.68 Million 250.71 Million 73.64 Million
Good Will 127.6 Million 125.47 Million 114.86 Million 117.55 Million 125.68 Million -
Intangible Assets 467.14 Million 212.19 Million 199.93 Million 159.12 Million 125.03 Million 73.64 Million
Long-Term Investments 72.47 Million 60.3 Million -233.41 Million -842.53 Million -55.69 Million 5.88 Million
Tax Assets 348.4 Million 101.47 Million 34.53 Million 21.64 Million 13.27 Million 4.61 Million
Other Non Current Assets 1.19 Million 18.99 Million 343.71 Million 963.64 Million 99.75 Million 8.94 Million
Other Assets 1.00 - - - - 1.00
Total Liabilities 3.64 Billion 3.84 Billion 2.81 Billion 3.97 Billion 2.07 Billion 981.21 Million
Total Current Liabilities 3.08 Billion 2.7 Billion 2.26 Billion 2.8 Billion 2.03 Billion 947.41 Million
Account Payables 537.73 Million 505.11 Million 458.87 Million 502.22 Million 487.67 Million 512.44 Million
Tax Payables 29.3 Million 7.28 Million 31.8 Million 21.88 Million 31.3 Million 20.68 Million
Short Term Debt 2.1 Billion 1.95 Billion 1.57 Billion 2.13 Billion 1.36 Billion 319.94 Million
Deferred Revenue 35.93 Million 38.22 Million 220.76 Million 142.5 Million 138.55 Million 20.68 Million
Other Current Liabilities 412.48 Million 204.02 Million 16.15 Million 28.91 Million 38.71 Million 94.33 Million
Total Non Current Liabilities 562.93 Million 1.13 Billion 547.67 Million 1.16 Billion 41.01 Million 33.79 Million
Long-Term Debt 512.37 Million 1 Billion 474.58 Million 1.12 Billion 6.17 Million 6.17 Million
Deferred Revenue Non Current 76.56 Million 84.98 Million 65.5 Million 38.14 Million 34.84 Million 27.62 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -63.33 Million 6.17 Million 6.17 Million 6.17 Million -6.17 Million 27.62 Million
Other Liabilities 1.00 - 1.00 - 1.00 1.00
Total Equity 5.79 Billion 6.16 Billion 5.4 Billion 3.74 Billion 3 Billion 2.42 Billion
Stock Holders Equity 5.8 Billion 6.17 Billion 5.37 Billion 3.72 Billion 2.96 Billion 2.42 Billion
Common Stock 1.61 Billion 1.61 Billion 1.24 Billion 934.16 Million 718.47 Million 552.42 Million
Retained Earnings 3.06 Billion 3.43 Billion 2.76 Billion 2.22 Billion 1.71 Billion 1.24 Billion
Accumulated other comprehensive income 552.9 Million 545.79 Million 406.59 Million 417.33 Million 186.35 Million 119.38 Million
Common Stock Equity 5.8 Billion 6.17 Billion 5.37 Billion 3.72 Billion 2.96 Billion 2.42 Billion
Capital Lease Obligation 13.23 Million 15.94 Million - - - -
Total Investments 754.46 Million 61.6 Million 26.38 Million 3.25 Million 936.06 Thousand 3.83 Million
Total Debt 2.62 Billion 2.96 Billion 2.04 Billion 3.25 Billion 1.36 Billion 319.94 Million
Net Debt 1.41 Billion 1.57 Billion 1.38 Billion 2.76 Billion 1 Billion -114.85 Million

Balance Sheet Charts